Thursday, March 26, 2020 1:12:14 AM
Statement on the Coronavirus and Global Supply of Medicines
Indivior is closely monitoring developments relating to COVID-19 (novel coronavirus) outbreak.
Our priority remains the ongoing supply of medicines to healthcare providers and patients, the
health and safety of our employees and the well-being of the patients we serve.
We are actively managing our global supply chains to minimize any potential disruption. Our
executive management and supply team are together working with internal and external business
partners and regulatory authorities to assess and mitigate the potential impact of COVID-19. We are
committed to helping ensure that patients will continue to have an ongoing supply of their
medication. Based on our assessment and environment we do not currently expect to have any
material supply interruptions.
We are also following guidelines provided by international health authorities and all global, national
and local government mandates regarding measures to keep our workforce and communities safe.
We have instituted a remote work policy for office and field-based staff leveraging all available
technology to ensure essential activities will continue to provide patients, healthcare providers and
other key stakeholders with the supports they need.
We will continue to monitor the situation closely, placing the needs of patients first at all times.
C4urself the 1st Ammendment.
Don't assume that i don't know, and i wont assume, that you have no idea.
Recent INDV News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/13/2024 12:28:50 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/09/2024 03:49:36 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/09/2024 10:22:01 AM
- Indivior Announces Q1 2024 Financial Results • PR Newswire (US) • 04/25/2024 06:00:00 AM
- Indivior Announces Publication Demonstrating that OPVEE® (nalmefene) Nasal Spray Rapidly Reverses Effects of Opioid-Induced Respiratory Depression in Head-to-Head Study Against Intranasal Naloxone • PR Newswire (US) • 03/11/2024 06:43:00 PM
- Court Provides Final Approval of Settlement with Direct Purchaser Class in the Multidistrict Antitrust Litigation; Final Court Approval Concludes the Antitrust Multidistrict Litigation • PR Newswire (US) • 02/29/2024 07:02:00 AM
- Indivior Announces Q4 / FY 2023 Financial Results • PR Newswire (US) • 02/22/2024 07:00:00 AM
- Indivior Announces Q3 2023 Financial Results • PR Newswire (US) • 11/09/2023 07:05:00 AM
- Indivior Announces Q3 2023 Financial Results • PR Newswire (US) • 11/09/2023 07:05:00 AM
- Indivior Enters an Exclusive Licensing Agreement with Alar Pharmaceuticals • PR Newswire (US) • 10/11/2023 08:20:00 PM
- Indivior Publishes Real World Data Showing SUBLOCADE® May Reduce Non-Fatal Overdoses Among Individuals with Opioid Use Disorder in Canada • PR Newswire (US) • 09/26/2023 06:30:00 PM
- Indivior Reaches Agreement with End Payor Class to Resolve Their Antitrust Multi-District Litigation Claims • PR Newswire (US) • 08/21/2023 06:02:00 AM
- Indivior Reaches Agreement with End Payor Class to Resolve Their Antitrust Multi-District Litigation Claims • PR Newswire (US) • 08/21/2023 06:02:00 AM
- Indivior Announces Q2/H1 2023 Financial Results • PR Newswire (US) • 07/27/2023 06:00:00 AM
- Indivior Announces Four Abstracts Accepted for Presentation at the 85th Annual Scientific Meeting of the College on Problems of Drug Dependence • PR Newswire (US) • 06/14/2023 05:53:00 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM